Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Mavik aproved for marketing in U.S.

May 10, 1996

RS-66252 selective for AT1 receptors in vitro

May 10, 1996

Antihypertensive activity reported for FR-149581

May 10, 1996

E. Merck continues to investigate angiotensin II blockers

May 10, 1996

Servier develops S-18149 as putative venotropic agent

May 3, 1996

CPC-111 enters phase II for angioplasty indication

May 3, 1996

Nasal propranolol claimed by RiboGene for angina Rx

May 3, 1996

Novel PAI-1 inhibitor protects against vascular lesions

May 3, 1996

TEI-9063 structure linked to new patent

May 3, 1996

AHP claims smooth muscle cell proliferation inhibitors for restenosis

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...